Tag: pharmaceuticals
-
A.I. Discovery Companies to Find Rare Disease Drugs
A joint venture of two drug discovery and design companies aims to create new biotechnology businesses to find drugs for treating rare diseases.
-
Guidelines Proposed for Complex Clinical Trials
A working group published guidelines for conducting clinical trials that simultaneously test multiple cancer treatments and can change course over time.
-
Biotech Options Enzyme Inhibitors for Lung Cancer
A biotechnology company developing inhaled drugs for respiratory diseases agreed to provide Johnson & Johnson with access to its technology for treating lung cancer.
-
Science & Enterprise Year in Review
Our most-viewed new story is from an academic/industry research team in Australia that tells how a synthetic cannabidiol, or CBD, compound is as effective as current antibiotics against a class of microbes.
-
Synthetic Bio Cancer Immunotherapy Company Acquired
A biotechnology company creating synthetic proteins that invoke the immune system to fight cancer is being acquired by drug maker Astellas Pharma.
-
Commentary – New Models Needed for Antibiotic Resistance
Many parts of a new model for fighting antibiotic resistance are in development, and the pieces still need to be assembled, but the outline of a precision-medicine rather than mass-produced drug model is beginning to emerge.
-
FDA Blocks Monthly HIV Drug Combo
The U.S. Food and Drug Administration rejected a combination of experimental and existing drugs given once a month to treat HIV.
-
Engineered Viruses Licensed for Cancer Therapies
A biotechnology company developing cancer immunotherapies with synthetic viruses is licensing its technology to Takeda Pharmaceuticals.
-
Patch Device Stores Vaccine Record in Skin
A plastic vaccine patch is shown in lab animals to also store an invisible record of that vaccination under the recipient’s skin, displayed with a smartphone.
-
Duke Univ Forms Drug Development Company
Duke University and life science investor Deerfield Management are forming a new enterprise to develop drug candidates through early development stages.